What is Sentry BioPharma Services?
Sentry BioPharma Services operates as a premier contract service organization, providing essential supply chain solutions for temperature-sensitive clinical and commercial pharmaceutical products. The company distinguishes itself through a robust portfolio that includes GMP-compliant storage, vaccine distribution, and comprehensive clinical trial management. With a footprint spanning 40 countries, Sentry ensures the integrity and security of sensitive medical assets, including controlled substances. Their operational model is built upon a foundation of rigorous regulatory compliance and quality assurance, making them a vital partner for life science organizations navigating complex import and export landscapes.
How much funding has Sentry BioPharma Services raised?
Sentry BioPharma Services has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Sentry BioPharma Services
PPP
Public-Private Partnership
What's next for Sentry BioPharma Services?
With the successful acquisition of this late-stage financing, Sentry BioPharma Services is poised to accelerate its operational scaling and technological integration. The company is expected to leverage this capital to enhance its cold chain logistics capabilities and expand its global distribution network. As the demand for secure, compliant pharmaceutical transport continues to rise, Sentry's strategic focus will likely shift toward optimizing its digital infrastructure and increasing its capacity for managing high-stakes clinical trial logistics. This growth trajectory positions the firm to capture additional market share in the evolving biopharmaceutical services landscape.
See full Sentry BioPharma Services company page
